Søren W. Rasmussen

Medicin og biovidenskab

1. semaglutide 100%
2. Glucagon-Like Peptide-1 Receptor 95%
3. Type 2 Diabetes Mellitus 85%
4. Liraglutide 80%
5. Chronic Renal Insufficiency 55%
6. Kidney 48%
7. Blood Pressure 38%
8. Randomized Controlled Trials 36%
9. Diabetic Nephropathies 22%
10. Glomerular Filtration Rate 22%
11. Confidence Intervals 22%
12. Sodium-Glucose Transport Proteins 15%
13. Mineralocorticoid Receptor Antagonists 14%
14. Clinical Trials 13%
15. Renin-Angiotensin System 11%
16. Glycated Hemoglobin A 11%
17. Dyslipidemias 10%
18. Hyperglycemia 9%
19. Body Weight 9%
20. LDL Cholesterol 9%
21. Renal Insufficiency 9%
22. Disease Progression 8%
23. Creatinine 8%
24. Albuminuria 7%
25. Renal Replacement Therapy 7%
26. Obesity 7%
27. Therapeutics 6%
28. Hypertension 6%
29. Guidelines 6%
30. Weights and Measures 6%
31. Leukocyte Count 6%
32. Morbidity 6%
33. Population 5%
34. Mortality 5%
35. Hemoglobins 5%